AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
Log in

NYSE:VSIVitamin Shoppe Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$6.50
MA: $1,340.11▼
$22,700.00
52-Week Range N/A
Volume3.50 million shs
Average Volume386,074 shs
Market Capitalization$156.65 million
P/E Ratio25.00
Dividend YieldN/A
Beta1.58
Vitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition products, and other health and wellness products of approximately 900 brands, such as own brands comprising The Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, and Betancourt Nutrition; and national brands, including Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, Megafood, and Nature's Way. The company sells its products through Vitamin Shoppe and Super Supplements retail stores, as well as through its vitaminshoppe.com Website. As of November 7, 2018, it operated 775 company-operated retail stores under the Vitamin Shoppe and Super Supplements retail banners. It also operates franchise stores. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey.
Read More
Vitamin Shoppe logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.47 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Food stores
Sub-IndustrySpecialty Stores
SectorRetail/Wholesale
Current SymbolNYSE:VSI
Previous Symbol
CUSIP92849E10
CIK1360530
Webwww.vitaminshoppe.com
Phone201-868-5959

Debt

Debt-to-Equity Ratio2.34
Current Ratio1.16
Quick Ratio0.21

Price-To-Earnings

Trailing P/E Ratio25.00
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.11 billion
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow2.60
Book Value$7.85 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)$0.26
Net Income$-3,750,000.00
Net Margins-0.83%
Return on Equity2.81%
Return on Assets0.74%

Miscellaneous

Employees5,136
Outstanding Shares24,100,000
Market Cap$156.65 million
Next Earnings DateN/A
OptionableOptionable

Receive VSI News and Ratings via Email

Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter.

Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Vitamin Shoppe?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitamin Shoppe in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Vitamin Shoppe.

How were Vitamin Shoppe's earnings last quarter?

Vitamin Shoppe Inc (NYSE:VSI) posted its quarterly earnings data on Thursday, August, 8th. The specialty retailer reported $0.20 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.12 by $0.08. The specialty retailer earned $270.88 million during the quarter, compared to analyst estimates of $278.60 million. Vitamin Shoppe had a positive return on equity of 2.81% and a negative net margin of 0.83%. View Vitamin Shoppe's earnings history.

What price target have analysts set for VSI?

1 Wall Street analysts have issued 1-year price objectives for Vitamin Shoppe's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Vitamin Shoppe's stock price to reach $4.00 in the next year. View analysts' price targets for Vitamin Shoppe.

Has Vitamin Shoppe been receiving favorable news coverage?

News headlines about VSI stock have trended very negative on Thursday, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vitamin Shoppe earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave media coverage about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutVitamin Shoppe.

Who are some of Vitamin Shoppe's key competitors?

What other stocks do shareholders of Vitamin Shoppe own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitamin Shoppe investors own include GNC (GNC), Ford Motor (F), salesforce.com (CRM), Ring Energy (REI), Ring Energy (REI), Transocean (RIG), BGC Partners (BGCP), Consolidated Communications (CNSL), Costco Wholesale (COST) and Cisco Systems (CSCO).

Who are Vitamin Shoppe's key executives?

Vitamin Shoppe's management team includes the following people:
  • Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 51)
  • Ms. Sharon M. Leite, CEO & Director (Age 56)
  • Mr. Charles D. Knight, Interim CFO, Sr. VP & Chief Accounting Officer (Age 55)
  • Mr. Andrew Laudato, CTO & Exec. VP (Age 52)
  • Mr. David Morrison, VP of Scientific & Regulatory Affairs

What is Vitamin Shoppe's stock symbol?

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How big of a company is Vitamin Shoppe?

Vitamin Shoppe has a market capitalization of $0.00 and generates $1.11 billion in revenue each year. The specialty retailer earns $-3,750,000.00 in net income (profit) each year or $0.26 on an earnings per share basis. Vitamin Shoppe employs 5,136 workers across the globe.

What is Vitamin Shoppe's official website?

The official website for Vitamin Shoppe is www.vitaminshoppe.com.

How can I contact Vitamin Shoppe?

Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.